- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02691845
Initiating and Maintaining Physical Activity in Depressed Individuals (Project MOVE)
The investigators propose a randomized clinical trial in which 240 depressed individuals are assigned to one of three arms, with each successive arm having an added component that may serve to increase and maintain physical activity:
- brief advice (BA) to exercise (control condition);
- BA + supervised & home-based exercise (SHE) + health education (HE) contact control; and
- BA + SHE+ cognitive-behavioral sessions focused on increasing and maintaining exercise (CBEX).
The primary aim is to assess and optimize the safety, feasibility, acceptability of each intervention component, as well as barriers limiting their effectiveness in order to prepare for a larger scale randomized clinical trial.
Study Overview
Status
Conditions
Detailed Description
The investigators propose a randomized clinical trial in which 240 depressed individuals are assigned to one of three arms, with each successive arm having an added component that may serve to increase and maintain physical activity:
- brief advice (BA) to exercise (control condition);
- BA + supervised & home-based exercise (SHE)+health education (HE) contact control; and
- BA+SHE+ cognitive-behavioral sessions focused on increasing and maintaining exercise (CBEX).
There are two phases for participants: intervention phase (3 months), which consists of intensive contact, and the follow-up phase (6 months). BA will consist of one, 45-minute session about public health recommendations, and strategies for getting started. SHE will be a 12-week intervention consisting of 1x/week supervised exercise plus exercise prescriptions for home-based exercise with the goal of gradually achieving the public health recommendation of 150 minutes/week of moderate-to-vigorous physical activity (MVPA), CBEX and HE sessions will be individual, 30-minute, weekly sessions during the intervention phase. CBEX will address barriers to physical activity that are particularly pronounced in depression -i.e., anhedonia, decreased motivation, and decreased energy, as well as poor problem-solving skills. During the follow-up phase, groups who received SHE during the intervention phase will receive brief, monthly phone check-ins from an exercise specialist.
Primary Aims:
- To compare the efficacy of the 3 arms for increasing physical activity during the 12-week intervention phase. We hypothesize that BA + SHE + CBEX will be superior to BA + SHE + HE, and that BA + SHE + HE will be superior to BA alone in terms of objectively measured MVPA levels.
To compare the longer-term impact of the three arms on objectively-measured minutes of MVPA at 6- and 9-month follow-ups (i.e., follow-up phase). Hypotheses are the same as for the intervention phase (aim #1).
Secondary Aims:
- To assess the impact of proposed intervention combinations on depression, physical health outcomes including cardiorespiratory fitness and body composition, and self-reported MVPA in all phases. Hypotheses mirror those described in our primary aims above.
- To determine whether amount of MVPA mediates the association between group assignment and change in depressive symptoms. We hypothesize that amount of MVPA will serve as a mediator.
- To examine behavior change theory-based mediators of the association between group assignment and MVPA. Hypothesized mediators include: perceived benefits of exercise, perceived barriers to exercise, exercise self-efficacy, intrinsic motivation to exercise, and identified motivation to exercise.
- To examine whether social and environmental barriers to exercise predict exercise maintenance.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02906
- Butler Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Sedentary, i.e., have not participated regularly in moderate-to-vigorous physical activity (MVPA) for 90 minutes per week or more for more than 6 weeks of the past 12 weeks.
- Medically cleared for MVPA, documented by a note from their primary care provider.
- No significant medical condition or physical disability that would interfere with physical activity or study participation. The investigators will exclude individuals with significant cardiovascular disease, hematologic disorders, and autoimmune disorders. The investigators will also exclude individuals who are planning a surgery in the next 9 months and those with dementia.
- Elevated depression symptoms. To meet criteria for elevated symptoms, participants must have a QIDS score of 8 or greater (i.e., at least moderate depression levels), and must have a score of "1" or greater on at least one of the two core DSM-V depressive symptoms, i.e., sad mood or anhedonia. -
- No current bulimia or anorexia (past 3 months); no MDD with psychotic symptoms (past 6 months); no history of bipolar disorder, schizophrenia, or a chronic psychotic condition; (assessed using the SCID).
- No hazardous drug or alcohol use in the past 6 months, as assessed by: a. no substance abuse treatment in the past 6 months; and b. does not meet criteria for a moderate or severe substance use disorder in the past 6 months.
- Depression is not very severe, i.e., QIDS score is <= 20.
- No suicidality requiring immediate treatment.
- Not pregnant or planning on becoming pregnant in the next year.
- Understands English sufficiently well to consent and complete study assessments.
- Aged 18-65.
- Able to make one of the 2 available exercise class times.
- Able to walk 1 mile
- Weight does not exceed 375 lbs.
- If participants are aged 60 or older, or if there is any concern about their cognitive capacity, participants will undergo a brief cognitive functioning screener, the Montreal Cognitive Assessment (MOCA). Participants are required to achieve a score within 1 SD of the mean for their age and education level to participate in the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: BA
Brief advice to exercise.
This serves as a control condition.
|
|
Active Comparator: BA + SHE + HE
Brief advice to exercise + supervised & home-based exercise + health education
|
|
Experimental: BA + SHE + CBEX
Brief advice to exercise + supervised & home-based exercise + cognitive-behavioral sessions focused on increasing and maintaining exercise
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in minutes of moderate-vigorous physical activity (MVPA) per week assessed via accelerometer
Time Frame: from baseline to 3 months, 6 months, 9 months
|
from baseline to 3 months, 6 months, 9 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
change in depression assessed via Quick Inventory of Depression Symptoms
Time Frame: Baseline to 3 months, 6 months, 9 months
|
depression assessed via blind evaluator using the Quick Inventory of Depression Symptoms (QIDS)
|
Baseline to 3 months, 6 months, 9 months
|
change in cardiorespiratory fitness
Time Frame: Baseline to 3 months, 6 months, 9 months
|
Baseline to 3 months, 6 months, 9 months
|
|
change in self-report of MVPA assessed via International physical activity questionnaire
Time Frame: Baseline to 3 months, 6 months, 9 months
|
Baseline to 3 months, 6 months, 9 months
|
|
change in Self-report of pain assessed via the SF-36
Time Frame: Baseline to 3 months, 6 months, 9 months
|
Baseline to 3 months, 6 months, 9 months
|
|
change in Self-report of overall health assessed via the SF-36
Time Frame: Baseline to 3 months, 6 months,9 months
|
Baseline to 3 months, 6 months,9 months
|
|
change in Self-report of physical functioning assessed via the SF-36
Time Frame: Baseline to 3 months, 6 months, 9 months
|
Baseline to 3 months, 6 months, 9 months
|
|
number, severity, impairment of adverse events
Time Frame: 3 months, 6 months, 9 months
|
3 months, 6 months, 9 months
|
|
change in anxiety assessed via state-trait anxiety inventory
Time Frame: Baseline to 3 months, 6 months, 9 months
|
Baseline to 3 months, 6 months, 9 months
|
|
change in irritability assessed via Brief irritability test
Time Frame: Baseline to 3 months, 6 months, 9 months
|
Baseline to 3 months, 6 months, 9 months
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R01HL127695 (U.S. NIH Grant/Contract)
- R56HL127695 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Lawson Health Research InstituteTerminated
Clinical Trials on BA (brief advice)
-
University of ChicagoNational Alliance for Research on Schizophrenia and DepressionCompleted
-
University of Missouri, Kansas CityNational Cancer Institute (NCI)CompletedSmoking | Tobacco Use | Nicotine DependenceUnited States
-
Brown UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Memorial Hospital... and other collaboratorsCompletedAlcohol Consumption | Unsafe SexUnited States
-
VA Office of Research and DevelopmentCompletedDrinking, AlcoholUnited States
-
University of Texas at AustinNational Institute on Drug Abuse (NIDA)Completed
-
University of Texas at AustinThe University of Texas Health Science Center, Houston; Baylor College of Medicine and other collaboratorsCompletedPrenatal Alcohol Exposure | Prenatal Tobacco Exposure | Prenatal Marijuana ExposureUnited States
-
Yale UniversityNational Institute on Drug Abuse (NIDA)CompletedMarijuana Abuse | Alcohol Abuse | Cocaine AbuseUnited States
-
Clinica Universidad de Navarra, Universidad de...University of NavarraCompletedSmoking | Smoking CessationSpain
-
University of British ColumbiaNational Institutes of Health (NIH)Completed